4.8 Article

Optimized base editors enable efficient editing in cells, organoids and mice

Journal

NATURE BIOTECHNOLOGY
Volume 36, Issue 9, Pages 888-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.4194

Keywords

-

Funding

  1. NIH/NCI [CA195787-01, U54OD020355]
  2. Starr Cancer Consortium [I10-0095]
  3. American Cancer Society [RSG-17-202-01]
  4. Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant [SU2C-AACR-DT22-17]
  5. American Association for Cancer Research
  6. National Cancer Institute (NCI) [NIH T32 CA203702]
  7. National Institute of General Medical Sciences of the NIH [T32GM07739]
  8. NCI/NIH [1 F31 CA224800-01, F31CA192835, CA 181280-01]
  9. MSKCC TROT program [5T32CA160001]
  10. HHMI Hanna Gray Fellow
  11. Geoffrey Beene Chair of Cancer Biology
  12. Howard Hughes Medical Institute
  13. Helmholtz Association [VH-NG-1114]
  14. German Research Foundation (DFG) [B05, SFB/TR 209]

Ask authors/readers for more resources

CRISPR base editing enables the creation of targeted single-base conversions without generating double-stranded breaks. However, the efficiency of current base editors is very low in many cell types. We reengineered the sequences of BE3, BE4Gam, and xBE3 by codon optimization and incorporation of additional nuclear-localization sequences. Our collection of optimized constitutive and inducible base-editing vector systems dramatically improves the efficiency by which single-nucleotide variants can be created. The reengineered base editors enable target modification in a wide range of mouse and human cell lines, and intestinal organoids. We also show that the optimized base editors mediate efficient in vivo somatic editing in the liver in adult mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available